Abstract

Schizophrenia is a psychiatric diagnosis that indicates a mental disorder characterized by abnormal perception or disturbances regarding reality. A number of abnormalities in patients with schizophrenia have been linked to the field of psychoneuroimmunology. Schizophrenia occurs due to various factors (multifactorial), including genetic factors, environment and neurological abnormalities. Psychologically, schizophrenia occurs due to a mismatch between affection, cognition and behavior. Neurologically, in schizophrenia there is overactivity of the dopaminergic system, in the main dopamine pathway, namely in the mesolimbic, mesocortex, nigrostriatal and tuberoinfundibular, as well as increased serotonergic activity. Meanwhile, immunologically, schizophrenia occurs due to changes in microglia activity which affects the immune response and an increase in pro-inflammatory cytokines. The clinical manifestations of schizophrenia consist of 3 categories of symptoms, in the form of positive symptoms, negative symptoms and cognitive symptoms/interpersonal relationship disorders. Management of schizophrenia is carried out comprehensively with pharmacological antipsychotic treatment and psychosocial therapy which aims to improve quality of life and reduce morbidity and mortality of the disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.